Dr. Barahimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1959 NE Pacific Street
Box 356160
Seattle, WA 98195Phone+1 206-598-6110Fax+1 206-598-1363
Education & Training
University of WashingtonFellowship, Gastroenterology, 2016 - 2019- University of WashingtonResidency, Internal Medicine, 2013 - 2016
- University of Washington School of MedicineClass of 2013
Certifications & Licensure
WA State Medical License 2013 - 2025
MT State Medical License 2015 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- 11 citationsSafety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.Scott D. Lee, Anand Singla, Jason Harper, Mitra Barahimi, Jeffrey Jacobs
Inflammatory Bowel Diseases. 2021-08-04 - 39 citationsDevelopmental changes in propagation patterns and transmitter dependence of waves of spontaneous activity in the mouse cerebral cortex.Jay I. Conhaim, Curtis R. Easton, Matthew I. Becker, Mitra Barahimi, Emily R. Cedarbaum
The Journal of Physiology. 2011-05-15 - 5 citationsTofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.Scott David Lee, Anand Singla, Jason Harper, Mitra Barahimi, Jeffrey Jacobs
Digestive Diseases and Sciences. 2022-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
